Arizona Arthritis and Rheumatology Research, PLLC

Phoenix, Arizona 85307

0 studies enrolling now · 15 studies all time

What they study most

Arthritis, Psoriatic, Arthritis, Rheumatoid, Behçet's Syndrome, Diabetic Foot, Gout, Myositis, Peripheral Arterial Disease, Raynaud Phenomena, Raynaud's Disease, Rheumatoid Arthritis, Scleroderma, Systemic Sclerosis

Studies at this site

• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis — Completed
• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
• Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD. — Stopped early
• A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies — Running, not enrolling
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis — Stopped early
• A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis — Completed
• A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products — Completed
• A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease — Completed
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis — Completed
• Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) — Completed
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® — Completed
• Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis — Completed
• Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab — Completed